Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

COMPARING EFFECTS OF NINTENDO EXERGAMING TO A NO INTERVENTION CONTROL GROUP

17 juli 2026 bijgewerkt door: Anjana Bhat, University of Delaware

Exergaming Intervention Study

This is a pilot randomized clinical trial to evaluate the feasibility and acceptability, and preliminary outcomes of delivering a Nintendo Switch exergaming (NE group) intervention in a group of autistic youth with autism spectrum disorder (ASD) between 5 and 30 years compared to an age-matched, no intervention control group of autistic youth (Control group) .

Studie Overzicht

Toestand

Voltooid

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

Parents of each ASD participant completed a screening form and the parent and participant completed an additional screening interview before participating in a pretest visit to confirm study eligibility.

After the motor and cognitive pretests and parent questionnaires were completed and eligibility was confirmed, each participant was randomly assigned to the Nintendo exergaming (NE) intervention or no intervention control group.

Each participant in the NE group received 8 weeks of exergaming intervention for 45-60 minutes per session @2 sessions per week. After the intervention period was completed motor and cognitive posttests and parent questionnaires were completed to assess preliminary outcomes.

We also completed feasibility and acceptability measures using parent, trainer, and child surveys.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

30

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

  • Verenigde Staten
    • Delaware
      • Newark, Delaware, Verenigde Staten, 19060
        • Health Sciences Campus, University of Delaware

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind
  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • A school or medical record of holding an autism diagnosis

Exclusion Criteria:

  • Did not follow 1 to 2-step instructions at the pretest.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Nintendo Switch Exergaming
This group received 8 weeks of Nintendo Switch Exergaming Intervention @ 2 days per week for 45-60 minutes per session. Pretests and posttests were completed before and after this period.
Gedragsmatig: Nintendo Switch Exergaming
Each exergaming intervention session included RingFit warm-up, RingFit Adventure Games to target multiple motor domains including body coordination, strength, and endurance and the Nintendo Switch Sports virtual sports targeted body coordination and visuomotor skills.
Geen tussenkomst: No Intervention Control Group
This group received 8 weeks of business as usual control period. Pretests and posttests were completed before and after this period.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Bruininks Oseretsky Test of Motor Performance
Tijdsspanne: Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
The BOT-2 is a standardized motor test that is a reliable and valid motor measure for youth between the ages of 4 to 21 years (Bruininks & Bruininks, 2005). Participants' gross motor skills were assessed using the balance (BAL), bilateral coordination (BLC), strength (STN), and agility (AGIL) subtests of BOT-2. Subtests are combined to provide a body coordination (BC, includes BAL and BLC), strength/agility (SA, includes STR and AGIL) and manual coordination (MC, includes MD and ULC) composite standard score at pretest and posttest. Change in composite standard scores (BC, SA, and MC) were assessed between pretest and posttest performance.
Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Bilateral Motor Coordination Subtest of there Sensory Integration and Praxis Test (SIPT-BMC) Battery
Tijdsspanne: Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
The SIPT BMC subtest assesses a youth's ability to imitate 22 novel hand and feet rhythmic actions shown by the tester. During the test, the tester asks the child to repeat bilateral rhythmic sequences of the hands or feet. An error occurrs if the youth does correctly imitate the sequence or rhythm of the tester's movements. A spatial error was scored if the youth's scale or pattern of movement differed from that of the tester. A temporal error occurred if the youth paused during the motor sequence, or moved slow/fast compared to tester. Total spatial and temporal errors were calculated across all imitated actions at pretest and posttest.
Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
Developmental Coordination Disorder Questionnaire (DCD-Q)
Tijdsspanne: Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
Parents completed the 15-item motor screening tool to report their child's fine- motor, gross-motor, and general coordination abilities compared to their peers. The total score at pretest and posttest were compared.
Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
Behavior Rating Inventory of Executive Function (BRIEF)
Tijdsspanne: Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
Parents completed the BRIEF to assess the youth's executive functioning skills during everyday tasks. The total score at pretest and posttest was compared.
Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
Computerized Modified Flanker Task
Tijdsspanne: Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
All participants completed the Modified Flanker Task to assess the inhibitory control component of executive functioning. The task consisted of four experimental blocks, with incongruent and congruent conditions presented in random order within each block of 30 trials, with 15 incongruent and 15 congruent trials. a) Congruent: Five fish facing in the same direction, b) Incongruent: The outer four fish faced the same direction while the center fish faced the opposite direction. Participants were instructed to click the arrow button on the screen to indicate the direction of the center fish and to respond as quickly and accurately as possible. We compared the average reaction time at pretest and posttest.
Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
Computerized Modified Stroop Word-Color Task
Tijdsspanne: Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.
The Stroop Task assessed the task switching, flexibility, and response inhibition components of executive functioning. The task consisted of two conditions: Color and Word. Participants were instructed to press the button on the screen to match the color of the letters shown in the color condition, or to match the spelling of the word shown in the Word condition. Each block consisted of 40 trials. Average reaction times at pretest and posttest were compared.
Pretest and posttests were conducted within 2 weeks before or after intervention, respectively.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

University of Delaware

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

2 mei 2023

Primaire voltooiing (Werkelijk)

26 maart 2024

Studie voltooiing (Werkelijk)

26 maart 2024

Studieregistratiedata

Eerst ingediend

17 juli 2026

Eerst ingediend dat voldeed aan de QC-criteria

17 juli 2026

Eerst geplaatst (Werkelijk)

22 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

22 juli 2026

Laatste update ingediend die voldeed aan QC-criteria

17 juli 2026

Laatst geverifieerd

1 juli 2026

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • 1947455

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Nintendo Switch Exergaming

Zoek naar vergelijkbare onderzoeken

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

CROs by country

CROs in Armenia

Voorwaarden

Zeldzame ziekten

Geneesmiddelinterventies

Voedingssupplementen

Sponsor / medewerkers

Locaties

Abonneren